PubMed

Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer.

Sellahewa C, Nightingale P, Carmichael AR.

Int Semin Surg Oncol. 2008 Feb 24;5:2.PMID: 18294401 [PubMed - in process]Related articlesFree article

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

Kavanagh DO, Chambers G, O'Grady L, Barry KM, Waldron RP, Bennani F, Eustace PW, Tobbia I.

BMC Cancer. 2009 Jan 1;9:1.PMID: 19118499 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased expression of osteopontin in patients with triple-negative breast cancer.

Wang X, Chao L, Ma G, Chen L, Tian B, Zang Y, Sun J.

Eur J Clin Invest. 2008 Jun;38(6):438-46. Epub 2008 Apr 30.PMID: 18452545 [PubMed - indexed for MEDLINE]Related articles

Expression of Cyclooxygenase-2 in Human Breast Cancer: Relationship with HER-2/neu and other Clinicopathological Prognostic Factors.

Nam E, Lee SN, Im SA, Kim DY, Lee KE, Sung SH.

Cancer Res Treat. 2005 Jun;37(3):165-70. Epub 2005 Jun 30.PMID: 19956498 [PubMed - in process]Related articlesFree article

Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.

Naeem M, Nasir A, Aman Z, Ahmad T, Samad A.

J Ayub Med Coll Abbottabad. 2008 Jul-Sep;20(3):23-6.PMID: 19610508 [PubMed - indexed for MEDLINE]Related articles

Biomarkers associated with breast cancer are associated with obesity.

Sauter ER, Scott S, Hewett J, Kliethermes B, Ruhlen RL, Basarakodu K, de la Torre R.

Cancer Detect Prev. 2008;32(2):149-55. Epub 2008 Jul 17.PMID: 18639389 [PubMed - indexed for MEDLINE]Related articles

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

Breast Cancer Res. 2009;11(1):R11. Epub 2009 Feb 24.PMID: 19239686 [PubMed - indexed for MEDLINE]Related articlesFree article

[Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer]

Zhang J, Zhang JH, Liu Y, Hao XM, Fang ZX, Li SL.

Zhonghua Yi Xue Za Zhi. 2007 Dec 11;87(46):3268-71. Chinese. PMID: 18396622 [PubMed - indexed for MEDLINE]Related articles

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.

Breast Cancer Res. 2008;10(5):R86. Epub 2008 Oct 16.PMID: 18925950 [PubMed - indexed for MEDLINE]Related articlesFree article

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL.

J Clin Oncol. 2008 Jul 10;26(20):3324-30.PMID: 18612148 [PubMed - indexed for MEDLINE]Related articles

Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.

Mizell J, Smith M, Li BD, Ampil F, Chu QD.

Ann Surg Oncol. 2009 Oct;16(10):2711-6. Epub 2009 Jul 11.PMID: 19593633 [PubMed - indexed for MEDLINE]Related articles

Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.

Pintens S, Neven P, Drijkoningen M, Van Belle V, Moerman P, Christiaens MR, Smeets A, Wildiers H, Vanden Bempt I.

J Clin Pathol. 2009 Jul;62(7):624-8.PMID: 19561231 [PubMed - indexed for MEDLINE]Related articles

C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.

Sharifah NA, Lee BR, Clarence-Ko CH, Tan GC, Shiran MS, Naqiyah I, Rohaizak M, Fuad I, Tamil AM.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):663-70.PMID: 19271345 [PubMed - indexed for MEDLINE]Related articles

Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways.

Siddiqa A, Long LM, Li L, Marciniak RA, Kazhdan I.

BMC Cancer. 2008 May 2;8:129.PMID: 18454859 [PubMed - indexed for MEDLINE]Related articlesFree article

[Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression]

Fan Y, Guan Y, Zhao WH, Li Q, Xu BH.

Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):917-20. Chinese. PMID: 19173993 [PubMed - in process]Related articles

High prevalence of HER-2/neu overexpression in female breast cancer among an Iraqi population exposed to depleted uranium.

Al-Dujaily EA, Al-Janabi AA, Pierscionek T, Yasseen AA.

J Carcinog. 2008;7:8.PMID: 19008567 [PubMed - in process]Related articlesFree article

Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.

Sharif MA, Mamoon N, Mushtaq S, Khadim MT.

J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.PMID: 19208313 [PubMed - indexed for MEDLINE]Related articles

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.

Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X.

BMC Cancer. 2008 Mar 28;8:83.PMID: 18373849 [PubMed - indexed for MEDLINE]Related articlesFree article

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. Epub 2008 Jan 25.PMID: 18296077 [PubMed - indexed for MEDLINE]Related articles

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M.

Clin Cancer Res. 2008 Sep 15;14(18):5849-55.PMID: 18794096 [PubMed - indexed for MEDLINE]Related articlesFree article